TP53 and melanoma: Patient’s pEVs inhibited tumor cell proliferation in an miR-34a–dependent manner (Fig 5E), but, unlike EV from maDC, barely modulated p53 protein levels, although p53 was present in the tumor lines we analyzed (Fig 5A) and is generally not mutated in melanoma.